Skip to main content

Valeura Energy Inc.: Q4 2025 Update and 2026 Guidance

SINGAPORE, Jan. 13, 2026 (GLOBE NEWSWIRE) — Valeura Energy Inc. (TSX:VLE, OTCQX:VLERF) (“Valeura” or the “Company”) announces: (i) the Company’s Q4 2025 performance was in line with its guidance outlook for 2025 and resulted in a new record cash position; (ii) completion of a successful drilling campaign at Block B5/27 drove strong ongoing oil production and is expected to contribute to reserves replacement; and (iii) a guidance outlook for 2026 supporting its objective to continue generating long-term value for shareholders.  Q4 and Full Year 2025 HighlightsRecord cash position of US$305.7 million as at 31 December 2025 with no debt; Oil production averaged 24,721 bbls/d in Q4 2025, resulting in full year average oil production of 23,242 bbls/d(1) for 2025; 2.523 million bbls of oil were sold in...

Continue reading

The subscription period in Karolinska Development AB (publ)’s rights issue begins today

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA, JAPAN, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH KOREA, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER TO, OR INVITATION TO, ACQUIRE OR SUBSCRIBE FOR ANY SECURITIES IN KAROLINSKA DEVELOPMENT AB (PUBL) IN ANY JURISDICTION. PLEASE ALSO REFER TO THE SECTION “IMPORTANT INFORMATION” BELOW. Today, 13 January 2026, the subscription period begins in Karolinska Development AB (publ)’s (“Karolinska Development” or the “Company”) rights issue of series B shares of approximately SEK 202.6 million before deduction of transaction costs, resolved by the Board of Directors on 1 December 2025 and approved by the...

Continue reading

INVL Renewable Energy Fund I repaid a EUR 17.5 million loan to Cordiant Capital ahead of schedule

REFI Solar, a company of INVL Renewable Energy Fund I – an investment fund focusing on renewable energy projects and managed by INVL Asset Management, a leading alternative asset management group in the Baltics – has repaid in full a EUR 17.5 million loan to the global investment management firm Cordiant Capital nearly six months ahead of the original maturity date. The loan from Cordiant Capital was used to expand the capacity of solar parks under development in Poland and Romania, with a total combined capacity of 389 megawatts (MW). The financing enabled the company to support part of the construction phase of these projects and continue their successful development. Although the loan was originally due in May 2026, the company met its obligations early, supported by capital successfully raised from local investors. “This is an important...

Continue reading

Sidetrade Advances Security Leadership with SOC 1® Type II, SOC 2® Type II Reports and ISO 27001 Certification as AI Footprint Expands

Sidetrade, the Order-to-Cash AI company, announced it has obtained SOC 1® Type II and SOC 2® Type II reports with an unmodified auditor’s opinion, following audits conducted by EY France, and completed a full ISO/IEC 27001:2022 recertification. The results validate the company’s control maturity, data protection practices, and operational resilience at scale, as enterprises increasingly demand verifiable assurances on AI governance and financial process integrity, particularly in regulated environments. The SOC (System and Organization Controls) reporting framework provides independent assurance on the design and operating effectiveness of controls over time. Following audits conducted by EY France, Sidetrade received SOC 1® Type II and SOC 2® Type II reports with an unmodified auditor’s opinion, confirming that its internal controls were...

Continue reading

EARLY CLOSURE OF SUBSCRIPTION PROCESS FOR 5TH TRANCHE OF UAB “KVARTALAS” BONDS

UAB “Kvartalas”, legal entity code 305475438, with its registered address at Jogailos St. 4, Vilnius, Republic of Lithuania (the Issuer), announces that, due to sufficient investor demand, the Issuer has decided to end the subscription process for the offering of the 5th tranche of bonds (ISIN LT0000411167), effective as of the time of this announcement. New subscription orders are no longer accepted. As of the time of this announcement, Nasdaq Exchange Members shall not accept any new subscription orders from investors. By 11:00 today (13 January 2026) the Members may only enter into the Exchange Trading System previously received buy orders that have not yet been entered. Any orders entered into the Exchange Trading System after 11:00 will not be processed and will not be eligible for bond allocation. Please note that the results of...

Continue reading

Banqup announces advanced negotiations with Fitek Oü for the sale of its Baltic companies

Press Release – Inside Information La Hulpe, Belgium – 13 January 2026, 7:00 a.m. CET – INSIDE INFORMATION – Banqup Group SA (Euronext: BANQ) (Banqup, Company), a leading provider of integrated business communications solutions, today announced that it is in advanced negotiations with Fitek Oü regarding a potential transaction involving the sale of all shares in its operational Baltic companies. The transaction is targeted for completion by the end of February 2026, subject to obtaining formal approval from the relevant competition authorities in Estonia, Latvia and Lithuania.  [Inside Information] Key transaction detailsThe portfolio of the companies in the Baltics comprises 3 operating entities (one in each jurisdiction). Banqup’s product suite in the Baltics includes € 0,3 million Digital Banqup revenue, € 4,0 million...

Continue reading

Basilea joins INCATE to support antifungal innovation

Allschwil, Switzerland, January 13, 2026 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today a partnership with INCATE (INCubator for Antibacterial Therapies in Europe), an antimicrobial incubator supporting the advancement of early stage anti-infectives. Basilea is joining INCATE as an industry partner, bringing extensive preclinical, clinical, and commercial expertise in anti-infectives and, for the first time, expanding INCATE’s scope to include antifungals, hence addressing the critical need for novel antifungal therapies. Through this partnership, Basilea will help INCATE to identify and support the most promising early-stage innovations and strengthen the bridge between emerging ideas...

Continue reading

CHC Navigation Introduces APACHE 4 PRO: A Multi-Purpose USV for Comprehensive Hydrographic Surveys

CHCNAV APACHE 4 ProCHCNAV APACHE 4 Pro Hydrographic and Bathymetric Surveys USVSHANGHAI, Jan. 13, 2026 (GLOBE NEWSWIRE) — CHC Navigation (CHCNAV), a global provider of geospatial solutions, announces the launch of the APACHE 4 PRO, a versatile Unmanned Surface Vessel (USV) designed for a wide range of hydrographic and bathymetric survey applications. By integrating a rugged hull design, versatile instrument compatibility, and intelligent navigation capabilities, the APACHE 4 PRO provides a reliable platform for detailed underwater mapping and environmental monitoring. Adaptable Platform for Diverse Survey PayloadsThe APACHE 4 PRO is engineered for mission flexibility. The USV seamlessly accommodates various mainstream Acoustic Doppler Current Profilers (ADCPs) and integrates with the CHCNAV HQ-400 Multibeam Echo Sounder...

Continue reading

Innventure, Inc. Announces Pricing of $40 Million Registered Direct Offering of Common Stock

With the proceeds from the offering, Innventure expects to fully repay all outstanding convertible debentures ORLANDO, Fla., Jan. 12, 2026 (GLOBE NEWSWIRE) — Innventure, Inc. (NASDAQ: INV) (“Innventure” or the “Company”), an industrial growth conglomerate, today announced it has entered into securities purchase agreements with four institutional investors for the purchase and sale of 11,428,572 shares of common stock for gross proceeds of approximately $40 million, before deducting placement agent fees and offering expenses. The offering is expected to close on or about January 14, 2026, subject to the satisfaction of customary closing conditions. The Company expects to use the net proceeds from this offering to repay all outstanding obligations under the convertible debentures, subject to the terms of the securities purchase agreement,...

Continue reading

Visionary Holdings Inc. Reports Fiscal Year 2025 Annual Report

Highlighting Strategic Transformation and Early Commercial Progress in Emerging Health Businesses TORONTO, Jan. 12, 2026 (GLOBE NEWSWIRE) — Visionary Holdings Inc. (Nasdaq: GV) (the “Company”) today announced the disclosure of its Annual Report on Form 20-F for the fiscal year ended March 31, 2025, outlining the Company’s strategic transformation, business restructuring progress, and financial performance. During the reporting period, the Company continued to advance its transition from a traditional education- and real estate-focused business toward a diversified platform centered on health management, anti-aging and premium medical aesthetics, complemented by its AI-enabled education business. Emerging health-related businesses generated initial revenue contributions during the fiscal year, representing early progress in the...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.